Jianping Lei

Papers

Total Citations

H-Index

About

Jianping Lei is a pioneering researcher at the forefront of nanomedicine and targeted cancer therapy, with a particular focus on designing intelligent micro/nanomotors (MNMs) for precision drug delivery. His most cited work introduces a groundbreaking strategy to overcome a critical limitation in enzyme-powered MNMs—their rapid deactivation within the hostile tumor microenvironment. By ingeniously leveraging hydrogen bond-rich metal-organic frameworks (MOFs), Lei developed anti-biopassivated urease-powered micromotors that maintain propulsion and therapeutic efficacy even under biopassivation conditions. This innovation, detailed in his 2025 paper on bladder cancer therapy, has already garnered 10 citations, signaling its immediate impact on the field. Lei’s contributions bridge materials chemistry and biomedical engineering, offering a robust platform for active, long-lasting drug delivery systems. His work not only addresses a fundamental challenge in nanomotor design but also opens new avenues for treating aggressive cancers. With a growing citation footprint, Jianping Lei is establishing himself as a key innovator in the next generation of autonomous therapeutic nanodevices.